Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments
MWN-AI** Summary
The health-conscious consumer shift is driving notable growth in the zero-sugar beverage market, predicted to expand from $350 billion in 2024 to $500 billion by 2029. This transition underscores a demand for clean-label products featuring natural sweeteners and functional ingredients, as consumers increasingly gravitate towards items that are minimally processed. Companies such as Doseology Sciences, Jamieson Wellness, and Herbalife are well-positioned to capitalize on this trend, particularly in energy and wellness categories.
Doseology Sciences has launched its Feed That Brain Energy Pouches in the U.S., marking a significant step in its direct-to-consumer strategy. These pouches deliver non-nicotine energy in a sleek, discreet format without the need for inhalation, catering to modern consumer preferences for convenience. The oral nicotine pouch sector is forecast to grow even more dynamically, from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% annual growth rate driven by rising acceptance of pouch-based delivery systems.
Jamieson Wellness reported a promising 2025, achieving $822.1 million in revenue, a 13.4% increase from the previous year, while Herbalife's net sales reached $5.0 billion. Both companies are expanding their footprints in the health and wellness sectors, responding to increasing digital engagement and broadening distribution channels to meet evolving consumer demands.
Natural Health Trends recently executed a significant share buyback, demonstrating its commitment to shareholder value amidst growing consumer interest in wellness products. Overall, these developments across energy, wellness, and smokeless consumer segments reflect an evolving market landscape that prioritizes health, convenience, and innovative product delivery.
MWN-AI** Analysis
The demand for next-generation platforms across energy, wellness, and smokeless consumer segments is escalating rapidly, offering substantial investment opportunities. The structural shift toward health-conscious products is particularly evident in the beverage industry, where zero-sugar varieties have begun to dominate, generating six times more dollar growth than their regular counterparts. The overall market forecast suggests an expansion from $350 billion in 2024 to nearly $500 billion by 2029, driven largely by consumers seeking clean-label and naturally functional options.
For investors, this presents a unique opportunity, particularly in companies like Doseology Sciences (CSE: MOOD), Jamieson Wellness (TSX: JWEL), and Herbalife (NYSE: HLF). Doseology's recent launch of the Feed That Brain Energy Pouches reflects innovation in energy product formats, leveraging growing consumer preferences for discreet, non-nicotine alternatives to traditional energy delivery methods. As they expand their direct-to-consumer initiatives, investor sentiment may be positively influenced by potential uptake and repeat purchase behaviors.
Additionally, the oral nicotine pouch market is projected to grow significantly—from $5.4 billion in 2024 to over $25 billion by 2030—highlighting opportunities in nicotine alternatives. Major consumer goods players are integrating cognitive support elements into these formats, indicating a convergence of wellness and traditional energy products.
Companies like Jamieson Wellness are also announcing strong growth figures and expanding their product lines to cater to evolving consumer demands. For instance, Jamieson’s revenue growth spurred by its successful launch in China points to potential overseas market opportunities.
In summary, diversifying portfolios to include companies leveraging innovation in energy, wellness, and smokeless products could yield favorable results. As the market continues to mature, investing in firms that are adaptable and responsive to consumer trends will likely prove advantageous. Always consider consulting a financial advisor to align these opportunities with your specific investment strategy.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
Issued on behalf of Doseology Sciences Inc.
VANCOUVER, BC, March 5, 2026 /PRNewswire/ -- Consumers are voting with their wallets, and zero-sugar is winning. Zero-sugar beverages are driving 6x more dollar growth than regular varieties as buyers actively choose clean-label products with natural sweeteners and functional ingredients[1]. The global market is forecast to expand from $350 billion in 2024 toward $500 billion by 2029, fueled by health-conscious consumers who want naturally functional products without heavy processing[1]. This structural shift is creating validated demand for precision-dosed, portable formats across energy and wellness categories, positioning Doseology Sciences (CSE: MOOD) (OTCPK: DOSEF) (FSE: VU70), Jamieson Wellness (TSX: JWEL), Herbalife (NYSE: HLF), USANA Health Sciences (NYSE: USNA), and Natural Health Trends (NASDAQ: NHTC).
The oral nicotine pouch segment is forecast to climb from $5.4 billion in 2024 to over $25 billion by 2030, a 29.6% annual growth rate that validates rising acceptance of pouch-based delivery systems[2]. Major consumer goods companies are integrating cognitive support and adaptogens into modern oral formats, targeting wellness alongside traditional energy delivery[3].
Doseology Sciences (CSE: MOOD) (OTCPK: DOSEF) (FSE: VU70) just launched Feed That Brain Energy Pouches in the United States through a direct-to-consumer pilot program, marking the company's first DTC initiative in the U.S. market. Doseology specializes in pouch-based oral stimulant and cognitive support products. The rapidly expanding oral stimulant pouch sector is gaining momentum as consumers seek modern, discreet alternatives to traditional delivery formats. The pouches are now available exclusively to U.S. consumers at feedthatbrain.com and Amazon.com.
The U.S. pilot represents a key milestone in Doseology's strategy to validate oral pouch delivery as a scalable stimulant platform, beginning with non-nicotine energy products. Unlike combustible tobacco or vape products, oral stimulant pouches are smokeless and vapor-free, providing an alternative delivery method without inhalation. The company will use this phase to evaluate consumer adoption, usage frequency, and repeat purchase behavior.
"This U.S. pilot is a disciplined and deliberate step in Doseology's strategy to build a scalable oral stimulant platform," said Larry Latowsky, Executive Chairman of Doseology. "Feed That Brain demonstrates how controlled, non-nicotine energy delivery can meet evolving consumer preferences while generating the operational insight required for responsible growth."
Feed That Brain Energy Pouches are designed for modern, on-the-go use, offering consumers clarity and control without the volatility commonly associated with liquid energy formats. From a market perspective, the oral pouch category is experiencing strong global growth as consumers increasingly prioritize convenience, portability, and format innovation.
The company also recently appointed Larry Latowsky as Executive Chairman, bringing experience from his tenure as President and CEO of Katz Group Canada, which operated over 1,500 pharmacy locations. Latowsky cited the clarity of Doseology's strategy and team quality as reasons for joining, stating confidence in building a durable platform and unlocking significant long-term value.
Doseology also recently granted 140,000 restricted share units and 210,000 performance share units to a director, with RSUs vesting in equal monthly increments over 36 months and PSUs vesting upon achievement of defined performance milestones.
Read this and more news for Doseology at: https://equity-insider.com/2025/12/19/what-comes-after-cigarettes-vapes-and-energy-drinks/
In other industry developments and happenings in the market include:
Jamieson Wellness (TSX: JWEL) recently reported full-year 2025 revenue of $822.1 million, a 13.4% increase driven by 15.6% branded revenue growth across Canada, China, and the United States. The company's Jamieson Brands segment led performance with broad-based strength in all markets, while Youtheory delivered 20.2% revenue growth through e-commerce innovation and expanded traditional distribution.
"2025 was an outstanding year for Jamieson Wellness, driven by sustained global demand for our products and superior execution across every key market," said Mike Pilato, President and CEO of Jamieson Wellness. "As we look to 2026, consumers continue to prioritize their health and wellness, and we're well-positioned to meet them – across geographies, across channels, and across life stages."
The company issued 2026 guidance of $895-$935 million in consolidated revenue, representing 9-14% growth, with adjusted EBITDA of $174-$181 million. China revenue surged over 56% in 2025 as digital marketing deepened consumer engagement, while Jamieson's quality-focused marketing in Canada continued to outpace the broader vitamins and supplements market.
Herbalife (NYSE: HLF) recently reported fourth quarter 2025 net sales of $1.3 billion, up 6.3% year-over-year, with full-year 2025 net sales reaching $5.0 billion. Adjusted EBITDA exceeded guidance for both periods, and the company reduced its total leverage ratio to 2.8x by year-end while generating $333.3 million in net cash from operating activities.
"We exited 2025 with solid momentum, delivering Q4 and full-year net sales growth and adjusted EBITDA above guidance," said Stephan Gratziani, CEO of Herbalife. "Cristiano Ronaldo's investment in Pro2col reflects our shared ambition to scale personalized nutrition and wellness globally – uniting science, data, AI, innovation, and community to improve the health and performance of millions."
Cristiano Ronaldo invested $7.5 million for a 10% equity stake in Herbalife's Pro2col digital health platform, which launched its Beta 2.0 in the U.S., Canada, and Puerto Rico. The company issued 2026 guidance targeting net sales growth of 1-6% and adjusted EBITDA of $670-$710 million.
USANA Health Sciences (NYSE: USNA) recently reported fiscal year 2025 net sales of $925.3 million, an 8% increase year-over-year, driven by a full-year contribution from Hiya children's wellness brand and expanding omnichannel distribution. Fourth quarter net sales reached $226.2 million, up 6% year-over-year and sequentially, with adjusted diluted EPS of $0.60 exceeding consensus estimates.
"We began to see signs of stabilization in active customer counts in our core nutritional business as net sales in this segment increased modestly sequentially, led by growth in key markets including mainland China, the United States and Canada," said Kevin Guest, Chairman and CEO of USANA Health Sciences. "Meanwhile, our omnichannel brands, Hiya and Rise, posted solid year-over-year growth."
USANA's Rise Wellness brand tripled its sales in 2025 as distribution expanded into key retail outlets, with net sales outside the core nutritional business rising to 16% of consolidated revenue from approximately 1% in 2024. The company issued 2026 guidance of $925 million-$1.0 billion in net sales.
Natural Health Trends (NASDAQ: NHTC) recently announced the repurchase of all 2,935,227 shares held by the George K. Broady family for approximately $5.9 million at $2.00 per share, retiring roughly 25.5% of outstanding shares in a single negotiated transaction. The buyback was executed under the company's previously announced $70 million share repurchase program, with approximately $16 million remaining available for future repurchases.
"This privately negotiated transaction allows us to efficiently retire a large block of shares in a single, orderly transaction at an attractive price, addressing the perceived stock overhang and significantly reducing our shares outstanding," said Chris Sharng, President of Natural Health Trends.
Following the transaction, Natural Health Trends has 8,577,848 shares outstanding and expects annual dividend requirements to decline by approximately $1.2 million. The company is a leading direct-selling and e-commerce wellness products company focused on personal care and nutritional supplements across global markets.
CONTINUED… Read this and more news for Doseology at: https://equity-insider.com/2025/12/19/what-comes-after-cigarettes-vapes-and-energy-drinks/
CONTACT:
EQUITY INSIDER
info@equity-insider.com
(604) 265-2873
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity-Insider.com is a wholly-owned subsidiary of Market IQ Media Group, Inc. ("MIQ"). "). This article is being distributed for Maynard Communications ("MAY"), who has been paid a fee for an advertising campaign. MIQ has not been paid a fee for Doseology Sciences. Inc. advertising or digital media, but expects to be paid a fee from ("MAY"). There may be 3rd parties who may have shares of Doseology Sciences Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Doseology Sciences Inc., which were purchased as a part of a private placement. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material, including this article, which is disseminated by MIQ has been approved by Doseology Sciences Inc.; this is a paid advertisement, we currently own shares of Doseology Sciences Inc. and will buy and sell shares of the company in the open market, or through private placements, and/or other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
SOURCES:
- https://www.marketreportanalytics.com/reports/low-zero-sugar-beverages-259636
- https://www.grandviewresearch.com/press-release/global-nicotine-pouches-market
- https://www.insightaceanalytic.com/report/global-functional-beverages-market/1188
Logo - https://mma.prnewswire.com/media/2840019/5835646/Equity_Insider_Logo.jpg
FAQ**
How does Herbalife Nutrition Ltd. (HLF) plan to leverage its recent investments, such as Cristiano Ronaldo's stake in Pro2col, to enhance its competitive position in the rapidly growing zero-sugar beverage market?
What strategies are being implemented by Herbalife Nutrition Ltd. (HLF) to capitalize on the projected growth of the oral nicotine pouch market, particularly as consumer preferences shift toward smokeless alternatives?
With the anticipated growth in wellness products, how is Herbalife Nutrition Ltd. (HLF) differentiating its offerings to attract health-conscious consumers who prefer clean-label products with natural ingredients?
In light of the growing market for precision-dosed, portable consumer goods, how is Herbalife Nutrition Ltd. (HLF) adjusting its product development and marketing strategies to meet the evolving demands of modern consumers?
**MWN-AI FAQ is based on asking OpenAI questions about Doseology Sciences (OTC: DOSEF).
NASDAQ: DOSEF
DOSEF Trading
0.0% G/L:
$0.5475 Last:
500 Volume:
$0.5475 Open:
